Limitations in predicting PAM50 intrinsic subtype and risk of relapse score with Ki67 in estrogen receptor-positive HER2-negative breast cancer.
Oncotarget
; 8(13): 21930-21937, 2017 Mar 28.
Article
in En
| MEDLINE
| ID: mdl-28423537
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Tamoxifen
/
Breast Neoplasms
/
Receptors, Estrogen
/
Biomarkers, Tumor
/
Risk Assessment
/
Receptor, ErbB-2
/
Neoplasm Recurrence, Local
Type of study:
Etiology_studies
/
Incidence_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Female
/
Humans
Language:
En
Journal:
Oncotarget
Year:
2017
Type:
Article
Affiliation country:
Spain